These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 6291037)

  • 1. Immunofluorescent localization of the transforming protein of Rous sarcoma virus with antibodies against a synthetic src peptide.
    Nigg EA; Sefton BM; Hunter T; Walter G; Singer SJ
    Proc Natl Acad Sci U S A; 1982 Sep; 79(17):5322-6. PubMed ID: 6291037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunofluorescence on avian sarcoma virus-transformed cells: localization of the src gene product.
    Rohrschneider LR
    Cell; 1979 Jan; 16(1):11-24. PubMed ID: 217542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiserum specific for the carboxy terminus of the transforming protein of Rous sarcoma virus.
    Sefton BM; Walter G
    J Virol; 1982 Nov; 44(2):467-74. PubMed ID: 6292511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vinculin: a cytoskeletal target of the transforming protein of Rous sarcoma virus.
    Sefton BM; Hunter T; Ball EH; Singer SJ
    Cell; 1981 Apr; 24(1):165-74. PubMed ID: 6263485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the nature of crossreactions observed with antibodies directed to defined epitopes.
    Nigg EA; Walter G; Singer SJ
    Proc Natl Acad Sci U S A; 1982 Oct; 79(19):5939-43. PubMed ID: 6193510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adhesion plaques of Rous sarcoma virus-transformed cells contain the src gene product.
    Rohrschneider LR
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3514-8. PubMed ID: 6251464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of Rous sarcoma virus transformation mutants with differing tyrosine kinase activities to study the relationships between vinculin phosphorylation, pp60v-src location and adhesion plaque integrity.
    Kellie S; Patel B; Wigglesworth NM; Critchley DR; Wyke JA
    Exp Cell Res; 1986 Jul; 165(1):216-28. PubMed ID: 3011478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoskeletal association of pp60src. The transforming protein of the Rous sarcoma virus.
    Henderson D; Rohrschneider L
    Exp Cell Res; 1987 Feb; 168(2):411-21. PubMed ID: 3026821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myristic acid, a rare fatty acid, is the lipid attached to the transforming protein of Rous sarcoma virus and its cellular homolog.
    Buss JE; Sefton BM
    J Virol; 1985 Jan; 53(1):7-12. PubMed ID: 2981363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of p60src kinase activity in the induction of neuroretinal cell proliferation by rous sarcoma virus.
    Poirier F; Calothy G; Karess RE; Erikson E; Hanafusa H
    J Virol; 1982 Jun; 42(3):780-9. PubMed ID: 6284995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation of NH2-terminal glycine of p60src prevents both myristoylation and morphological transformation.
    Kamps MP; Buss JE; Sefton BM
    Proc Natl Acad Sci U S A; 1985 Jul; 82(14):4625-8. PubMed ID: 2991884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of reversion of Rous sarcoma virus transformation by herbimycin A: reduction of total phosphotyrosine levels due to reduced kinase activity and increased turnover of p60v-src1.
    Uehara Y; Murakami Y; Sugimoto Y; Mizuno S
    Cancer Res; 1989 Feb; 49(4):780-5. PubMed ID: 2463877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine structural mapping of a critical NH2-terminal region of p60src.
    Pellman D; Garber EA; Cross FR; Hanafusa H
    Proc Natl Acad Sci U S A; 1985 Mar; 82(6):1623-7. PubMed ID: 2984663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organization of pp60src and selected cytoskeletal proteins within adhesion plaques and junctions of Rous sarcoma virus-transformed rat cells.
    Shriver K; Rohrschneider L
    J Cell Biol; 1981 Jun; 89(3):525-35. PubMed ID: 6265469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation and metabolism of the transforming protein of Rous sarcoma virus.
    Sefton BM; Patschinsky T; Berdot C; Hunter T; Elliott T
    J Virol; 1982 Mar; 41(3):813-20. PubMed ID: 6178840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to a defined region of pp60src neutralize the tyrosine-specific kinase activity.
    Gentry LE; Rohrschneider LR; Casnellie JE; Krebs EG
    J Biol Chem; 1983 Sep; 258(18):11219-28. PubMed ID: 6411728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The absence of myristic acid decreases membrane binding of p60src but does not affect tyrosine protein kinase activity.
    Buss JE; Kamps MP; Gould K; Sefton BM
    J Virol; 1986 May; 58(2):468-74. PubMed ID: 3009860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino terminal myristylation of the protein kinase p60src, a retroviral transforming protein.
    Schultz AM; Henderson LE; Oroszlan S; Garber EA; Hanafusa H
    Science; 1985 Jan; 227(4685):427-9. PubMed ID: 3917576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small deletion in src of Rous sarcoma virus modifying transformation phenotypes: identification of 207-nucleotide deletion and its smaller product with protein kinase activity.
    Kitamura N; Yoshida M
    J Virol; 1983 Jun; 46(3):985-92. PubMed ID: 6304353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transformation by p60src with altered N-terminal sequences.
    Hanafusa H; Garber EA; Hanafusa T
    Princess Takamatsu Symp; 1986; 17():233-40. PubMed ID: 2843496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.